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SINTESIS, PENCIRIAN DAN SIFAT MESOMORFIK BAGI OLIGOMER 
ISOFLAVON SIMETRI DAN BUKAN SIMETRI  
ABSTRAK 
Empat siri baru oligomer hablur cecair simetri dan bukan simetri yang 
berdasarkan isoflavon telah disintesis dan dicirikan. Oligomer ini terdiri daripada tiga 
siri dimer bukan simetri, iaitu 7-[{4-[4'-((S)-2''-
metilbutiloksi)kabonilfenil]fenoksi}alkiloksi]-3-(4'-desiloksifenil)-4H-1-benzopiran-
4-on (BP-n-I), 7-[{4-[4'-((S)-2''-metilbutiloksi)kabonilfenil]fenoksi}desiloksi]-3-(4'-
tertukargantifenil)-4H-1-benzopiran-4-on (BPI-R) dan 7-[{4-[(4'-
metoksifenil)diazenil]fenoksi}alkiloksi]-3-(4'-metoksifenil)-4H-1-benzopiran-4-on 
(AB-n-I), dan satu siri trimer simetri: 1,3-bis{[3-(4'-desiloksifenil)-4H-1-benzopiran-
4-on-7-oksi]alkiloksi}benzena (BI-n-B). Kesemua oligomer mesogenik tersebut 
berbeza antara satu sama lain daripada segi kumpulan mesogen dan panjang spaser. 
Struktur molekul bagi sebatian oligomer ini telah diterangkan melalui spektroskopi 
CHN, FT-IR, 
1
H-NMR, 
13
C-NMR, 
1
H-
1
H COSY, 
1
H-
13
C HMQC dan 
1
H-
13
C HMBC 
sebelum penyiasatan sifat hablur cecair dijalankan dengan menggunakan POM, DSC 
and XRD. Mono- dan/atau polimorfisma telah diperhatikan bagi kesemua oligomer 
tersebut. Oligomer ini mempamerkan pelbagai fasa termasuk fasa nematik kiral (N*), 
fasa smektik A selapis dan ‘intercalated’ (SmA dan SmAc masing-masing), fasa 
smektik C ‘synclinic’ (SmCsyn) dan ‘anticlinic’ (SmCanti) mono- dan enantiotropik. 
Tambahan pula, kesan ganjil-genap yang ketara dalam suhu peralihan fasa (Tm dan 
Tc) telah diperhatikan bagi BP-n-I, AB-n-I dan homolog pendek BI-n-B (n = 3-7) 
apabila panjang spaser berubah. Suatu ciri khas yang perlu dikemukakan ialah 
tingkah laku jenis de Vries yang dipamerkan oleh homolog terpendek bagi BP-n-I. 
Selain itu, suatu perubahan geometri daripada bentuk rod ‘intercalated’ bagi 
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homolog pendek kepada bentuk bengkok bagi homolog panjang dalam BI-n-B 
menyebabkan pemerhatian tingkah laku mesomorfik yang luar biasa yang mana 
trimer pendek dan panjang mempamerkan SmA dan/atau fasa metastabil SmC 
manakala homolog dengan panjang spaser perantaraan bersifat nematogenik dengan 
julat suhu yang luas. 
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SYNTHESIS, CHARACTERIZATION AND MESOMORPHIC PROPERTIES 
OF SYMMETRIC AND NON-SYMMETRIC ISOFLAVONE OLIGOMERS 
ABSTRACT 
 Four new series of symmetric and non-symmetric isoflavone-based liquid 
crystal oligomers have been synthesized and characterized. These oligomers 
comprised of three series of non-symmetric dimers, namely 7-[{4-[4'-((S)-2''-
methylbutyloxy)carbonylphenyl]phenoxy}alkyloxy]-3-(4'-decyloxyphenyl)-4H-
1-benzopyran-4-ones (BP-n-I), 7-[{4-[4'-((S)-2''-methylbutyloxy)carbonyl 
phenyl]phenoxy}decyloxy]-3-(4'-substitutedphenyl)-4H-1-benzopyran-4-ones 
(BPI-R) and 7-[{4-[(4'-methoxyphenyl)diazenyl]phenoxy}alkyloxy]-3-(4'-
methoxy phenyl)-4H-1-benzopyran-4-ones (AB-n-I), and a series of symmetric 
trimers: 1,3-bis{[3-(4'-decyloxyphenyl)-4H-1-benzopyran-4-one-7-
oxy]alkyloxy}benzenes (BI-n-B). All oligomeric mesogens differ from one 
another in term of mesogenic moieties and spacer length. The molecular 
structures of these oligomers were elucidated via CHN, FT-IR, 
1
H-NMR, 
13
C-
NMR, 
1
H-
1
H COSY, 
1
H-
13
C HMQC and 
1
H-
13
C HMBC spectroscopy prior to the 
investigation of their liquid crystalline properties using POM, DSC and XRD. 
Mono- and/or polymorphism were observed in all oligomers. They exhibited a 
rich variety of phases including mono- and enantiotropic chiral nematic (N*), 
monolayer and intercalated smectic A (SmA and SmAc, respectively), synclinic 
(SmCsyn) and anticlinic smectic C (SmCanti) phases. Furthermore, pronounced 
odd-even effect in phase transition temperatures (Tm and Tc) upon varying the 
spacer length was observed for BP-n-I, AB-n-I and short homologues of BI-n-B 
(n = 3-7). One special feature worth mentioning was the de Vries type behaviour 
exhibited by the shortest homologue of BP-n-I. Apart from this, a crossover of 
xxv 
 
geometry from intercalated rod-shaped for short homologues to bent-shaped for 
long homologues in BI-n-B had resulted in the observation of an unusual 
mesomorphic behaviour wherein short and long trimers exhibited SmA and/or 
metastable SmC phase(s) while homologues with intermediate spacer length 
were purely nematogenic with broad temperature range. 
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1.0 INTRODUCTION 
1.1 Liquid crystals 
Liquid crystals (LCs) were first discovered by Fridrich Reinitzer, an Austrian 
Botanist in 1888. Reinitzer observed a strange behaviour of a material known as 
cholesteryl benzoate extracted from carrots (Reinitzer, 1888). This material has two 
distinct melting points. At 145.5 °C, it melted into a cloudy fluid prior to turning into 
a clear solution at 178.5 °C. Later, Reinitzer had discovered and described three 
important features of cholesteric liquid crystals (this name was coined by Georges 
Friedel in 1922): the existence of two melting points, the reflection of circularly 
polarized light and the ability to rotate the polarization direction of light. Further 
investigations of those phenomena were then carried out by Otto Lehmann, a 
German physicist (Collings and Hird, 1997).  
Liquid crystal is a state of matter that is intermediate between a solid 
crystalline and an isotropic liquid. Unlike a solid crystal in which molecules are 
positioned in fixed orientations with no translational freedom, liquid crystals possess 
some orientational order and little or no positional order. Similar to molecules in a 
liquid phase, liquid crystals molecules are able to move freely but remain oriented to 
a common axis, called a director. The arrangement of molecules in each phase is 
shown in Figure 1.1.                  
 
         
  
   
 
Figure 1.1: Arrangement of molecules in solid, liquid crystal and liquid (Shakhashiri, 
2007). 
Solid 
Liquid 
crystal 
Liquid 
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1.2 Types of liquid crystals 
 LCs can be divided into two classical categories: (i) lyotropic LCs 
(amphiphilic mesogens) which consist of two or more components that exhibit liquid 
crystalline properties in certain concentration range; (ii) thermotropic LCs (non-
amphiphilic anisometric mesogens) which exhibit a variety of phases as temperature 
is changed. However, thermotropic LCs remain the focus of this study and hence, 
lyotropic LCs will not be discussed further. 
1.3 Mesophases 
Typically, nematic and smectic are the two major types of mesophases, 
although many mesophases have been discovered in hitherto reported literatures (for 
the past 120 years). Among the many reported mesophases are the soft crystal phase, 
frustrated twist grain boundary (TGB) phases, chiral tilted smectic phases (exhibited 
by ferroelectric liquid crystals that include the chiral smectic C (SmC*) subphases) 
and the banana phases. 
1.3.1 Nematic phase 
 Molecules in the nematic (N) phase have orientational order but no positional 
order. On average, these molecules are all aligned towards a similar direction, 
referred to as the director (Figure 1.2 (a)) (Singh, 2000).  
1.3.1.1 Cholesteric phase 
 The cholesteric phase is also known as a chiral nematic (N*) phase in which 
the N phase is composed or induced by chiral molecules. In the N* phase as shown 
in Figure 1.2 (b), the molecular orientation in a plane rotates spirally in a direction 
perpendicular to the plane. The preferred orientation of molecules in N* forms a 
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helical structure with the helical axis perpendicular to the director (Devi and 
Bhattacharjee, 2010).  
 
 
 
 
 
Figure 1.2: Diagramatic representation of (a) N and (b) N* phases (Devi and 
Bhattacharjee, 2010). 
 
1.3.2 Smectic phase 
1.3.2.1 Smectic A phase 
 Molecules in smectic phases are ordered in layers and the translation of 
molecules from one layer to another is limited. Within these layered systems, a 
variety of molecular arrangements is possible. In the simplest, least ordered 
orthogonal smectic A (SmA) phase, there is no positional order within each layer and 
the long axes of the molecules are on average, positioned perpendicular to the layers 
(Figure 1.3 (a)) (Demus and Richter, 1980). 
1.3.2.2 Smectic C phase 
The smectic C (SmC) phase differs from SmA phase in term of molecular 
arrangement in which the molecules in the SmC phase are uniformly tilted at an 
angle, θ, relative to the layer normal, z (Figure 1.3 (b)). In general, the tilt angle 
increases with decreasing temperature. 
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Figure 1.3: Molecular arrangement in (a) SmA and (b) SmC phases ("Lemieux 
Group Organic Materials," 2006). 
 
1.3.2.3 Chiral smectic phase 
 In a chiral smectic phase, for example, the chiral smectic C (SmC*) phase, 
the molecules have positional ordering in a layered structure (as in other smectic 
phases), with the molecules tilted by a finite angle with respect to the layer normal. 
In SmC* phase, a bulk electrical polarization referred to as the spontaneous 
polarization (Ps), is present in the absence of any electrical field. These materials are 
(in general) ferroelectric. However, in the absence of external constraints, the SmC* 
phase forms a macroscopic helical structure in which the Ps of vector rotates from 
one layer to another relative to the helical axis and averages out to zero over a full 
helical pitch (Figure 1.4) (Collings and Hird, 1997). In this phase, the orientation of 
the tilt can be influenced by an electric field, and therefore, it can be used in displays, 
that in theory can be switched much faster than conventional nematic displays.  
1.4 Liquid crystal oligomers 
Research activity in LC oligomers can be traced back to the early 1980s, 
especially the development of semi-flexible main chain LC polymers (Ober et al., 
1984). These oligomers consisted of mesogenic units connected by flexible spacers. 
LC oligomers attracted considerable amount of attention as these compounds are 
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referred to as models for the semi-flexible main chain liquid crystal polymers (Imrie 
and Henderson, 2002; Pal et al., 2007). The remaining sections of this chapter will 
focus on the mesomorphic behaviours of LC dimers and trimers which are the scope 
of this study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4: A SmC* material showing the rotation of tilted director from layer to 
layer forming a helical structure (Clark and Lagerwall, 1980). 
 
1.4.1 Liquid crystal dimers 
LC dimers are the shortest liquid crystal oligomers. They composed of 
molecules containing two conventional mesogenic units connected by a flexible 
spacer, most commonly an alkyl chain. A symmetric dimer possesses two identical 
mesogenic moieties connected by a flexible spacer, while a non-symmetric dimer is 
formed by two different mesogenic units linked through a flexible spacer.  
1.4.2 Liquid crystal trimers 
A trimeric liquid crystal contains three mesogenic cores joined by two 
flexible spacers. In a similar manner to liquid crystal dimers, LC trimers can also be 
classified as symmetric and non-symmetric. For LC trimers, asymmetry can be 
introduced to their molecular structures by incorporating different mesogenic units 
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(either two or all three are different), flexible spacer or terminal chain length, 
terminal groups or some combination of these structural features. 
1.5 Structure-property relationship of liquid crystal oligomers 
1.5.1 Phase behaviour in liquid crystal oligomers 
A unique characteristic which has been noted for symmetric LC dimers is the 
decreasing tendency to exhibit smectogenic properties upon increasing spacer length 
(Date et al., 1992). For many dimeric LC, the smectic phase behaviour was also 
found to be suppressed when their mesogenic moieties (monomers) are smectogenic 
(Griffin and Britt, 1981). This phenomenon has been attributed to an increase in the 
overall molecular flexibility. It may be argued that the two rigid cores are joined by a 
flexible segment, but nevertheless the "center" of the structure is flexible. 
Furthermore, it is known that dimers with long terminal tails are able to 
promote smectic behaviour regardless of the spacer length (Luckhurst and Gray, 
1979). Some of them even exhibited a rich polymorphism of smectic phases, for 
example, α,ω-bis(4-(4'-n-decyloxyphenylethynyl)phenoxy)alkanes, which were 
reported by Rozhanskii I. L. (Rozhanskii et al., 1996). A simple relationship between 
the occurrence of smectic behaviour and the molecular structure of symmetric dimers 
was also deduced from the studies on α,ω-bis(4-n-alkyl-anilinebenzylidene-4’-
oxy)alkanes (Date et al., 1992). In order to obtain smectic properties, the terminal 
chain length must be greater than half the spacer length. Otherwise, N behaviour was 
observed. Generally, a simple monolayer smectic phase was observed for symmetric 
LC dimers containing long terminal chain which is thought to be stabilized by 
microphase segregation of three weakly distinct parts: terminal chain, mesogenic 
moiety and flexible spacer (Figure 1.5 (a)) (Imrie and Henderson, 2002).  
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Similar to LC dimers, increasing the spacer length does not necessary 
promote smectic behaviour in LC trimer. However, it was found that two 
homologues of a reported series of nematogenic symmetric LC trimers, 4,4'-bis[ω-
((4-cyanobiphenyl-4'-yloxy)alkoxy)alkoxy]biphenyls exhibited an additional 
monotropic SmA phase (Imrie and Luckhurst, 1998), whilst the corresponding 
dimeric series, α,ω-bis(4,4′-cyanobiphenyloxy)alkanes were exclusively nematogens 
(Emsley et al., 1984). Thus, smectic phase formation was more favourable for LC 
trimers than dimers with respect to these series. It was suggested that the enhanced 
smectic behaviour of this trimeric series may be attributed to a favourable specific 
interaction between the electron-rich biphenyl and the high electron affinity of the 
cyanobiphenyl moieities (Imrie et al., 2009). 
1.5.2 Layer arrangement of smectic phase in liquid crystal oligomers 
In general, symmetric dimers exhibit monolayer smectic phase, while non-
symmetric dimers tend to arrange in intercalated (Figure 1.5 (b)) or interdigitated 
(Figure 1.5 (c)) smectic organizations (Attard et al., 1994; Blatch and Luckhurst, 
2000). One of such examples is the α-(4-cyanobiphenyl-4'-yloxy)-ω-[4-(5-
alkylpyrimidine-2-yl)phenyl-4''-oxy]alkanes (Yoshizawa et al., 2006). In the 
intercalated smectic phase, the smectic layer periodicity, d is approximately half the 
molecular length, L (d/L ≈ 0.5). The intercalated arrangement is resulted from a 
specific interaction between the unlike mesogenic units enhanced by an entropy gain 
resulting from the homogeneously mixing of such groups (Blatch et al., 1997). The 
electrostatic quadrupolar interaction between the different mesogens having 
quadrupole moments of opposite signs is also believed to be another possible 
stabilizing factor (Blatch et al., 1995). In some cases, however, symmetric dimers are 
also known to exhibit intercalated mesophases (Watanabe et al., 1993). Contrary to 
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intercalated smectic phase, the layer thickness in interdigitated smectic phase is more 
than the length of one molecule but less than the length of two molecules, L < d < 2L. 
The driving force for this phase is however, not confined to only the presence of two 
unlike cores in the structure, as electrostatic interactions between certain groups like 
the polar and polarisable cyanobiphenyl groups in 1-(Cholest-5-en-3β-oxy)-ω-(4-
cyanobiphenyl-4'-oxy)alkanes, is known to play a key role in inducing interdigitation 
(Marcelis et al., 2003).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5: Diagramatic representation of SmA arrangements in dimeric liquid 
crystals, (a) monolayer, (b) intercalated and (c) interdigitated (Imrie and 
Henderson, 2002). 
 
Similar to LC dimers, most of the reported symmetric LC trimers have 
conventional monolayer smectic phase (Centore et al., 1990; Yoshizawa et al., 2007). 
Interestingly, a triply intercalated smectic phase (d/L ≈ 0.3) was found for several 
reported non-symmetric trimers (Donaldson et al., 2011; Henderson and Imrie, 2005; 
Marcelis et al., 2007). The driving force for the formation of this phase is considered 
to be electrostatic interactions between electron rich and electron deficient segments 
of the molecules. 
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1.5.3 Odd-even effect in liquid crystal oligomers 
Strong odd-even effects are usually observed for dimeric liquid crystals due 
to the parity of the spacer (Watanabe et al., 1993). The odd-even effect can be 
understood as a result of a conformational constraint whereby the molecules with an 
odd-parity spacer tend to assume a bent conformation with the two mesogens tilted 
and inclined to each other (Figure 1.6 (a)). In the even-parity spacer compounds, the 
mesogenic groups are more likely to have a zigzag conformation in which the 
mesogenic units are anti-parallel to each other (Figures 1.6 (b)) (Imrie and 
Henderson, 2007; Watanabe et al., 2000). That is why LC dimers with odd-parity 
spacers have a stronger tendency to form SmC-like phases while even-parity 
homologues and analogues form SmA phases (Niori et al., 1995; Watanabe et al., 
1993). In 1999, some additional striking properties of dimers with a flexible alkylene 
spacer were discovered (Choi et al., 1999; Watanabe et al., 1998). Some LC dimers 
with odd number of flexible units between the two mesogenic moieties adopted a 
bent conformation resulting in a liquid crystalline phase with electro-optical 
switching properties. Watanabe J. reported a chiral, anticlinic and antiferroelectric 
smectic phase formed by an achiral twin dimer with two identical mesogenic groups 
connected by an odd-parity spacer (Watanabe et al., 1998). Surprisingly, switching 
behaviour was also observed in dimers with an even number of flexible units in the 
central spacer (Prasad, 2001; Prasad et al., 2000,2001). However, no reasonable 
rationale for this observation was given.  
Figure 1.6: Diagramatic representation of dimeric molecules with (a) an odd and (b) 
an even number of flexible units between two mesogenic moieties. 
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The odd-even effect in transition temperatures and associated entropy 
changes observed for LC dimers are also found in trimeric liquid crystals as the 
length and parity of the spacers are varied, in which the even members exhibit higher 
values (Henderson et al., 2004; Imrie and Luckhurst, 1998). The magnitude of the 
alternation exhibited by the transition temperatures and associated entropy changes 
of the trimers are considerably greater than that exhibited by their analogous dimers 
on a relative scale (Imrie and Henderson, 2002). This trend is to be expected given 
the increase in shape anisotropy on passing from dimeric to trimeric molecules 
(Imrie et al., 2009). If a trimer is considered in its most extended all-trans 
conformation, two distinct molecular shapes are obtained depending on the parity of 
the spacers. The two outer mesogenic units of odd-parity trimers are inclined with 
respect to the central unit giving them a stretched ‘S’ shape (Figure 1.7 (a)), whereas 
in an even-parity trimer, all the three mesogenic units are co-parallel, resulting in an 
extended rod-like molecular structure (Figure 1.7 (b)). The even-parity trimers, 
therefore, have an enhanced shape anisotropy which allows the molecules to pack 
more efficiently in the liquid crystal phase, thus giving higher transition temperatures 
and entropy changes (Imrie and Henderson, 2007). 
  
Figure 1.7: Molecular shapes of the all-trans conformation of trimers containing      
(a) odd- and (b) even-parity flexible spacers. 
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1.5.4 Chirality effect on liquid crystalline properties of oligomers 
Chirality in liquid crystalline systems has been a major area of considerable 
research interest for both technological and fundamental reasons (Goodby, 1991; 
Mallia and Tamaoki, 2004). The presence of chiral centres in a mesogen can 
tremendously modify the organisation of the mesophases. Novel structures like the 
helical superstructure of N* and SmC* phases were induced (Nishiyama et al., 
2001,2002a). Tilted chiral smectic phases could exhibit spontaneous polarization and 
thus these mesophases were pyroelectric (Dierking, 2003). Coupling between 
chirality and oligomeric structures could also produce novel phenomena. Blatch and 
co-workers reported that chirality exhibited a dependence on the parity of the spacer, 
whereas blue phase I behaviour was observed in a very narrow temperature range 
(0.6 K) between isotropic liquid (Iso) and N* phases for the odd, non-symmetric 
dimers, whereas a direct Iso–N* transition was observed for the even, non-symmetric 
dimers (Blatch et al., 1997). Nishiyama I. also described unusual chirality-dependent 
phase behaviour of their designed chiral dimers, which showed ferrielectric and 
antiferroelectric phases with high values of tilt angles (Nishiyama et al., 2001,2002b). 
A direct ferroelectric smectic-to-isotropic phase transition was observed along with 
an isotropic to isotropic transition in the liquid phase; the racemic analogue, however, 
exhibited N-SmC phase sequence. Furthermore, Yelamaggad C. V. reported the 
mesomorphic properties of chiral unsymmetrical LC trimers: cholesteryl 6-{4-[4-[(4-
butylphenylazophenoxy)butoxy]phenylethynyl]phenoxy} hexanoate, with three non-
identical mesogenic units exhibiting both the twist grain boundary (TGB) and 
undulating TGB (UTGB) phases depending on the parity of the spacers (Yelamaggad 
et al., 2000; Yelamaggad et al., 2001).  
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1.6 Liquid crystals oligomers incorporating isoflavone moiety 
The effort in modifying the existing molecules, particularly natural products 
has well been considered as a viable approach that can lead to some novel and new 
compounds showing liquid crystalline properties (Hirose et al., 1989). Isoflavone 
made up the largest group of natural isoflavonoids (Adlercreutz et al., 1986). The 
pharmaceutical properties of isoflavones have been well documented (Boland and 
Donnelly, 1998; Chen et al., 2008; Kohen et al., 2007). Similar to many natural 
products possessing heterocycles in their structures including flavone and coumarin 
derivatives, isoflavone-based compounds in biological systems show remarkable 
liquid crystalline properties (Hirose et al., 1989). Figure 1.8 depicts a general 
structure of isoflavone. Chudgar N. K. and co-workers were the first researchers who 
synthesized and characterized liquid crystals derived from isoflavone (Chudgar et al., 
1991). Over the years, the mesogenicity of several isoflavone derivatives with 
classical calamitic structures containing one or two terminal chains have also been 
documented (Belmar, 1999; Chudgar et al., 1995; Chudgar and Shah, 1991). In order 
to study and understand the effect of different structural changes on the 
mesomorphism of these compounds, various modifications on existing molecules 
have been made, keeping in view the molecular geometry of the isoflavone moiety. 
The influence of different functional linkages, terminal chain length and polar 
terminal groups on the mesogenicity of liquid crystalline compounds have been 
reported (Yeap et al., 2009b; Yeap et al., 2008a; Yeap et al., 2007; Yeap et al., 
2008b). However, liquid crystal oligomers incorporating isoflavone moiety have not 
been reported. In order to establish the structure-property relationship of the 
isoflavone-based oligomers, four series of oligomeric liquid crystalline compounds 
with various structural modifications have been prepared. 
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Figure 1.8: A general structure of isoflavone (3-phenyl-4H-1-benzopyran-4-one). 
 
1.7 Research objectives 
The objectives of this study are: 
a) To synthesize and characterize new symmetric and non-symmetric isoflavone-
based, thermotropic liquid crystal oligomers.  
b) To investigate the effect of chirality on the liquid crystalline properties of these 
oligomers.   
c) To investigate the structure-property relationship of these oligomers. 
 
 
 
 
 
 
 
 
 
O
O
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2.0 EXPERIMENTAL 
2.1 Chemicals 
From Acros Organic, Belgium: 1,4-dibromobutane, 99%; 1,5-
dibromopentane, 97%; 1,6-dibromohexane, 98%; 1,8-dibromooctane, 98%; 1,9-
dibromononame, 97%; 1,10-diromodecane, 97%; 1,11-dibromoundecane, 98%; 1,12-
dibromododecane, 96%; 4-hydroxyphenylacetic acid, 98%; 4-methylphenylacetic 
acid, 99% and 4-methoxyphenylacxetic acid, 99%. From Tokyo Chemical Industry, 
Japan: 4-bromophenylacetic acid, 98%; 4-chlorophenylacetic acid, 97%; 4-
fluorophenylacetic acid, 98% and 4-(4-hydroxyphenyl)benzoic acid, 98%. From 
Sigma-Aldrich, United States of America: resorcinol, 99%; 1-bromodecane, 98%; 
phenol, 99%; 4-methoxyaniline, 99% and 1,7-dibromoheptane, 97%. From Fisher 
Scientific, United Kingdom: potassium carbonate anhydrous, 99%; potassium iodide, 
99% and hydrochloric acid, 37%. From R & M Chemical, United Kingdom: sodium 
nitrite, 98%; sodium hydroxide, 99%; potassium hydroxide, 85%. From Fluka, 
Switzerland: 1,3-dibromopropane and 99%; (S)-(-)-2-methyl-1-butanol, 95%. From 
Merck, Germany: boron trifluoride-diethyl ether complex, 50%; methanesulfonyl 
chloride, 99% and phenylacetic acid, 99%. From Avantor, United States of America: 
sulfuric acid, 98%. All chemicals were used without further purification. 
2.2 Instruments 
 CHN microanalyses were carried out on a Perkin Elmer 2400 LS 
Series CHNS/O analyzer at the School of Chemical Sciences, 
Universiti Sains Malaysia (USM). 
15 
 
 Fourier Transform Infrared (FT-IR) data were recorded using a Perkin 
Elmer 2000-FTIR spectrophotometer at the School of Chemical 
Sciences, USM. 
 1D and 2D Fourier Transform Nuclear Magnetic Resonance (FT-
NMR) were performed using a Bruker-Avance 300MHz, 400MHz or 
500MHz ultrashield spectrometer at the School of Chemical Sciences, 
USM. 
 Phase transition temperatures and enthalpy values of the synthetic 
compounds were measured using the following instruments: 
i. Seiko DSC6200R differential scanning calorimetry (DSC) at 
Tokyo Institute of Technology University, Japan. 
ii. TA Instrument DSC2000 at the Chemistry Department, 
Warsaw University. 
iii. Mettler Toledo DSC822e equipped with a TSO 801RO sample 
robot at the School of Natural and Computing Sciences, 
University of Aberdeen. 
 Textures of the mesophases were studied using a Carl Zeiss polarizing 
microscope equipped with a Linkam LTS350 hot stage and TMS94 
temperature controller at the Liquid Crystal Research Laboratory, 
School of Chemical Sciences, USM. 
 Layer spacing of liquid crystalline compounds during mesophase 
transitions was measured over a range of temperatures using a Bruker 
D8 Discover and GADDS system at the Laboratory of Dielectrics and 
Mechanics of the Chemistry Department, University of Warsaw. 
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 Dechiralization line distance that corresponds to the helical pitch was 
measured by using the pictures obtained from Zeiss microscope Axio 
Imiger at the Chemistry Department, University of Warsaw. 
2.3 Synthesis  
All compounds were synthesized and purified at normal atmospheric pressure 
by conventional method unless stated otherwise. 
 
2.3.1 Preparation of 7-[{4-[4'-((S)-2''-methylbutyloxy)carbonylphenyl]phenoxy} 
alkyloxy]-3-(4'-decyloxyphenyl)-4H-1-benzopyran-4-ones, BP-n-I (n = 3-12) 
The aforementioned were synthesized according to the synthetic routes 
shown in Figure 2.1. 
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Figure 2.1: Synthetic scheme for the formation of of 7-[{4-[4'-((S)-2''-
methylbutyloxy)carbonylphenyl]phenoxy}alkyloxy]-3-(4'-
decyloxyphenyl)-4H-1-benzopyran-4-ones, BP-n-I. 
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2.3.1.1 Synthesis of (S)-(-)-2-methylbutyl-4'-(4''-hydroxyphenyl)benzoate, HBP 
4-(4-hydroxyphenyl)benzoic acid (2.15 g, 0.01 mol) was added to (S)-(-)-2-
methyl-1-butanol (30 mL), which served as a reactant and solvent. A catalytic 
amount of concentrated H2SO4 was added dropwise and the reaction mixture heated 
to 90 °C for 24 hours. The resulting solution was cooled to room temperature and 
excess solvent was removed via evaporation. The crude product was then 
recrystallized from a solution of hexane and chloroform (1:2, v/v).   
2.3.1.2 Synthesis of 4-decyloxyphenylacetic acid, DPA 
2 equiv. of potassium hydroxide in methanol was added to a cold methanolic 
solution containing 4-hydroxyphenylacetic acid (10.70 g, 0.07 mol). Subsequently, 
1.2 equiv. of 1-bromodecane was added and the reaction mixture was heated under 
reflux for 18 hours. The solvent was subsequently removed and the reaction mixture 
was neutralized with 10 % of aqueous hydrochloric acid. The crude product was 
filtered off, washed thoroughly with water and recrystallized from methanol.     
2.3.1.3 Synthesis of 7-hydroxy-3-(4'-decyloxyphenyl)-4H-1-benzopyran-4-one, 
HDI 
HDI was synthesized according to the modified method reported by Wahala 
K. (Wahala and Hase, 1991). Under nitrogen atmosphere, a mixture containing 4-
decyloxyphenylacetic acid (8.50 g, 0.03 mol) and 1.1 equiv. of resorcinol in 
BF3.Et2O was heated for 4 hours at 70-75 °C. The reaction mixture was then cooled 
down to room temperature and dry DMF was added. The mixture was again heated 
to 50 °C and a solution of 3 equiv. of methanesulfonyl chloride in dry DMF was 
added slowly. After heating the reaction mixture for 1.5 hours at 75-80 °C, it was 
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poured into a rapid stirring of ice water bath upon which the crude product was 
formed. The product was then recrystallized from methanol.  
2.3.1.4 Syntheses of 7-(n-bromoalkyloxy)-3-(4'-decyloxyphenyl)-4H-1-
benzopyran-4-ones, Br-n-I (n = 3-12) 
HDI (0.50 g, 1.27 mmol) was mixed with 3 equiv. of the corresponding 
dibromoalkane in acetone. 3 equiv. of potassium carbonate anhydrous was then 
added to the solution and the mixture was refluxed for 6 hours. The reaction mixture 
was cooled to room temperature and excess solvent was removed via evaporation. 
Water was then added to the mixture and the resulting precipitate was filtered and 
dried. The crude product was recystallized from a solution of chloroform and ethanol 
(1:1, v/v). 
2.3.1.5 Syntheses of 7-[{4-[4'-((S)-2''-methylbutyloxy)carbonylphenyl]phenoxy} 
alkyloxy]-3-(4'-decyloxyphenyl)-4H-1-benzopyran-4-ones, BP-n-I (n = 3-12) 
Br-n-I (0.30 g) and 1.2 equiv. of HBP were dissolved in acetone. 3 equiv. of 
potassium carbonate anhydrous was then added to the solution, together with a 
catalytic amount of potassium iodide and the reaction mixture was refluxed for 12 
hours. The reaction mixture was cooled to room temperature and excess solvent was 
removed via evaporation Water was then added to the mixture and resulting 
precipitate filtered, washed with acetone and recrystallized from a solution of 
chloroform and ethanol (1:1, v/v).  
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2.3.2 Preparation of 7-[{4-[4'-((S)-2''-methylbutyloxy)carbonylphenyl]phenoxy} 
decyloxy]-3-(4'-substitutedphenyl)-4H-1-benzopyran-4-ones, BPI-R (R = H, CH3, 
OCH3, F, Cl, Br 
The aforementioned were synthesized according to the synthetic routes 
shown in Figure 2.2. 
 
Figure 2.2: Synthetic scheme for the formation of 7-[{4-[4'-((S)-2''-
methylbutyloxy)carbonylphenyl]phenoxy}decyloxy]-3-(4'-
substitutedphenyl)-4H-1-benzopyran-4-ones, BPI-R. 
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2.3.2.1 Syntheses of 7-hydroxy-3-(4'-substitutedphenyl)-4H-1-benzopyran-4-
ones, HI-R (R = H, CH3, OCH3, F, Cl, Br) 
HI-R were synthesized using a similar method as described in Section 2.3.1.3, 
wherein 4-decyloxyphenylacetic acid was replaced by phenylacetic acid, 4-
methylphenylacetic acid, 4-methoxyphenylacetic acid, 4-fluorophenylacetic acid, 4-
chlorophenylacetic acid and 4-bromophenylacetic acid. 
2.3.2.2 Syntheses of 7-(10-bromodecyloxy)-3-(4'-substitutedphenyl)-4H-1-
benzopyran-4-ones, BrI-R (R = H, CH3, OCH3, F, Cl, Br) 
BrI-R were synthesized using a similar method as described in Section 
2.3.1.4, wherein HDI was replaced by the corresponding HI-R and 1,10-
dibromodecane. 
2.3.2.3 Syntheses of 7-[{4-[4'-((S)-2''-methylbutyloxy)carbonylphenyl]phenoxy} 
decyloxy]-3-(4'-substitutedphenyl)-4H-1-benzopyran-4-ones, BPI-R (R = H, CH3, 
OCH3, F, Cl, Br) 
BPI-R were synthesized according to the method as described for Section 
2.3.1.5, wherein Br-n-I was replaced by the corresponding BrI-R. 
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2.3.3 Preparation of 7-[{4-[(4'-methoxyphenyl)diazenyl]phenoxy}alkyloxy]-3-
(4'-methoxyphenyl)-4H-1-benzopyran-4-ones, AB-n-I (n = 3-10) 
The aforementioned were synthesized according to the synthetic routes 
shown in Figure 2.3. 
 
 
Figure 2.3: Synthetic scheme for the formation of 7-[{4-[(4-
methoxyphenyl)diazenyl]phenoxy}alkyloxy]-3-(4'-methoxyphenyl)-4H-
1-benzopyran-4-ones, AB-n-I. 
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2.3.3.1 Synthesis of 4-[(4'-methoxyphenyl)diazenyl]phenol, HAB 
HAB was synthesized by adding an aqueous solution of sodium nitrite to a 
mixture of 4-methoxyaniline in concentrated hydrochloric acid, wherein the 
temperature of the mixture was kept within 0-5 °C. The cold mixture was then added 
dropwise to a cold mixture containing phenol, sodium hydroxide and water. 
Precipitate resulted from the acidification with aqueous hydrochloric acid was 
filtered and dried before recrystallized from acetone. 
2.3.3.2 Syntheses of 1-[4-(n-bromoalkyloxy)phenyl]-2-(4'-methoxyphenyl) 
diazene, AB-n-Br (n = 3-10) 
3 equiv. of potassium carbonate anhydrous was added to a solution 
containing HAB (0.5 g, 2.19 mmol) and 3 equiv. of the corresponding 
dibromoalkanes in acetone. The mixture was then refluxed for 6 hours. The reaction 
mixture was cooled to room temperature and excess solvent was removed via 
evaporation. Water was then added to the mixture and the resulting precipitate was 
filtered and dried. The crude product was purified by column chromatography using 
dichloromethane as eluent. 
2.3.3.3 Synthesis of 7-hydroxy-3-(4'-methoxyphenyl)-4H-1-benzopyran-4-one, 
HI-OCH3 
HI-OCH3 was synthesized using a similar method as described in Section 
2.3.1.3, wherein 4-decyloxyphenylacetic acid was replaced by 4-
methoxyphenylacetic acid. 
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2.3.3.4 Syntheses of 7-[{4-[(4'-methoxyphenyl)diazenyl]phenoxy}alkyloxy]-3-(4'-
methoxyphenyl)-4H-1-benzopyran-4-ones, AB-n-I (n = 3-10) 
3 equiv. of potassium carbonate anhydrous was added to a mixture of 
HIOCH3 (0.3 g, 1.12 mmol) and 0.83 equiv. of AB-n-Br in acetone. A catalytic 
amount of potassium iodide was then added and the reaction mixture was refluxed 
for 12 hours. The reaction mixture was cooled to room temperature and excess 
solvent was removed via evaporation. Water was then added to the mixture in order 
to remove the potassium carbonate and potassium iodide. The resulting precipitate 
was filtered, washed using acetone and recrystallized from a solution of chloroform 
and ethanol (1:1, v/v). 
 
 
 
 
 
 
 
 
 
 
 
